ArticleAmerican journal of human genetics2002

Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis.

Shih-hsin Kan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.